Clinical trials in Golnik

Innovative research focusing on severe asthma treatments, evaluating new therapeutic approaches for patients with moderate to severe uncontrolled conditions. Multiple trials are examining novel medications and their effectiveness in managing eosinophilic phenotypes.

• Uncontrolled Asthma Management
• Eosinophilic Phenotype Studies
• Long-term Treatment Evaluation

These studies aim to improve quality of life for patients with persistent respiratory symptoms.

Comprehensive studies on Non-Small Cell Lung Cancer (NSCLC), including early-stage and advanced cases. Trials are investigating innovative immunotherapy combinations and treatment approaches for various stages of the disease.

• Early-Stage NSCLC Treatment
• Immunotherapy Combinations
• Post-surgical Therapy

Research focuses on improving survival rates and treatment outcomes for lung cancer patients.

Advanced research into Progressive Fibrosing Interstitial Lung Diseases and related conditions. Studies are evaluating new therapeutic agents for long-term management and improvement of lung function.

• Idiopathic Pulmonary Fibrosis
• Progressive Pulmonary Fibrosis
• Lung Function Assessment

Trials aim to address the progression of fibrotic lung conditions and enhance treatment options.